Investment Adventures in Emerging Markets

A Prescription for Innovation
Perspective

A Prescription for Innovation

The word “innovation” is typically associated with technology, but innovation comes in many forms and across many industries. Franklin Templeton Emerging Markets Equity’s Krzysztof Musialik sees innovation taking place within the health care and pharmaceuticals industries in emerging markets—even driving change in developed markets.

Getting to Know Chetan Sehgal
Perspective

Getting to Know Chetan Sehgal

“In the 23 years I’ve been investing in emerging markets, the biggest change I’ve seen has been improvements in corporate governance. Sometimes, investors don’t realize how much difference legal, regulatory and institutional frameworks make, especially in emerging-market economies.” Chetan Sehgal, senior managing director, director of portfolio management, Franklin Templeton Emerging Markets Equity